These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19965932)

  • 1. Hepatocellular carcinoma for the non-specialist.
    Kumagi T; Hiasa Y; Hirschfield GM
    BMJ; 2009 Dec; 339():b5039. PubMed ID: 19965932
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis.
    Kuo YH; Lu SN; Chen CL; Cheng YF; Lin CY; Hung CH; Chen CH; Changchien CS; Hsu HC; Hu TH; Lee CM; Wang JH
    Eur J Cancer; 2010 Mar; 46(4):744-51. PubMed ID: 20060710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hepatocellular carcinoma in homozygous β-thalassemia cirrhotic patients.
    Gomatos IP; Alexakis N; Koskinas J; Smparounis SA; Katsaragakis S; Konstadoulakis MM; Zografos GC
    Am Surg; 2013 Jan; 79(1):111-3. PubMed ID: 23317624
    [No Abstract]   [Full Text] [Related]  

  • 4. Viral hepatitis and hepatocellular carcinoma.
    Marrero CR; Marrero JA
    Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatocellular carcinoma, from monitoring to treatment].
    Lupinacci RM; Menegaux F; Tresallet C
    Soins; 2013 Nov; (780):35-7. PubMed ID: 24409614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of hepatocellular carcinoma in chronic viral B and viral C liver diseases.
    Acalovschi M
    Rom J Gastroenterol; 2003 Jun; 12(2):123-30. PubMed ID: 12853999
    [No Abstract]   [Full Text] [Related]  

  • 7. A cohort study to investigate hepatocellular carcinoma risk in hepatitis C patients.
    Wang CH; Mo LR; Chang KK; Lin RC; Kuo JJ
    Hepatogastroenterology; 2011; 58(107-108):904-8. PubMed ID: 21830414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From viral hepatitis to hepatocellular carcinoma].
    Okita K
    Nihon Naika Gakkai Zasshi; 2001 Mar; 90(3):452-6. PubMed ID: 11307535
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatitis B and C virus markers in hepatocellular carcinoma].
    Tanikawa K
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):687-92. PubMed ID: 12442468
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
    Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
    Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in clinical characteristics, treatment and prognosis of hepatocellular carcinoma.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):1872-7. PubMed ID: 14696422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral hepatitis and hepatocellular carcinoma: update in 2012.
    Kudo M
    Dig Dis; 2012; 30(6):539-40. PubMed ID: 23258091
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fibrolamellar hepatocellular carcinoma in a patient with chronic viral B hepatitis].
    Da Ines D; Lannareix V; Petitcolin V; Bailly A; Charpy C; Abergel A; Chipponi J; Garcier JM
    Gastroenterol Clin Biol; 2009 May; 33(5):382-6. PubMed ID: 19361940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma.
    Branda M; Wands JR
    Hepatology; 2006 May; 43(5):891-902. PubMed ID: 16628664
    [No Abstract]   [Full Text] [Related]  

  • 15. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma, a rapidly increasing public health problem: the Tulane experience 2003-2009.
    Tangutur NK; Medvedev SF; Regenstein F; Balart LA
    J La State Med Soc; 2011; 163(4):185-90. PubMed ID: 21954650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma (HCC): a global perspective.
    Ferenci P; Fried M; Labrecque D; Bruix J; Sherman M; Omata M; Heathcote J; Piratsivuth T; Kew M; Otegbayo JA; Zheng SS; Sarin S; Hamid SS; Modawi SB; Fleig W; Fedail S; Thomson A; Khan A; Malfertheiner P; Lau G; Carillo FJ; Krabshuis J; Le Mair A;
    J Clin Gastroenterol; 2010 Apr; 44(4):239-45. PubMed ID: 20216082
    [No Abstract]   [Full Text] [Related]  

  • 18. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
    Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
    J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New insights from the German guideline "hepatocellular carcinoma"].
    Plentz RR; Malek NP;
    Dtsch Med Wochenschr; 2014 Dec; 139(49):2529-31. PubMed ID: 25423464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.